• Hirotaka Sato, Kentaro Takase, Aiko Harada, Iori Ozono, Yasuhide Kodama, Tomoko Ishitobi, Toshihiro Imada, Hideyuki Ohnuma, and Seikon Kin.
• Department of Nephrology, Shimane Prefectural Central Hospital, Japan.
• Intern. Med. 2022 Oct 1; 61 (19): 2911-2916.

AbstractA 59-year-old man undergoing hemodialysis was administered levetiracetam, after which he developed a systemic rash, high fever, severe liver dysfunction, and leukocytopenia with reactivation of human herpes virus 6. Atypical drug-induced hypersensitivity (DIHS) was diagnosed, and prednisolone was administered at 60 mg/day. However, liver failure rapidly progressed, and the patient died 12 days following treatment. Despite the rarity of DIHS with concomitant fulminant liver failure from levetiracetam and sufficient clearance thereof by hemodialysis, our case suggests that this syndrome may still ensue, resulting in mortality, even in hemodialysis patients. Although no treatment has yet been established, strict monitoring and aggressive treatment may be required.

19 keywords...

hide…